On November 16, Hinge Health, Inc. rose 4.39% in Regular Trading, trading at $119.83 per share, with turnover of $17.9752 million.
The move was supported by the company’s previously reported third-quarter results, which came in above expectations, along with a higher full-year revenue outlook that continued to underpin sentiment.
For the September quarter, revenue rose to $235 million from $154.2 million a year earlier, above consensus near $224.8 million, while adjusted earnings reached $0.71 per diluted share versus expectations of about $0.58. Management also guided fourth-quarter revenue to $249 million-$251 million, ahead of consensus near $239.7 million, and raised full-year revenue guidance to $879 million-$881 million from $856 million-$860 million. Analyst targets also moved higher afterward, including RBC lifting its target price to $135 while maintaining an Outperform rating.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments